InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
Pam3CSK4 | Cannabinoids induce functional Tregs by promoting tolerogenic DCs via autopha... | 2021 | Mucosal Immunol. | Angelina A. et al. | DOI: 10.1038/s41385-021-00455-x |
3-Methyladenine | Cannabinoids induce functional Tregs by promoting tolerogenic DCs via autopha... | 2021 | Mucosal Immunol. | Angelina A. et al. | DOI: 10.1038/s41385-021-00455-x |
Hygromycin B Gold | DOT1L O-GlcNAcylation promotes its protein stability and MLL-fusion leukemia ... | 2021 | Cell Rep | Song T. et al. | DOI: 10.1016/j.celrep.2021.109739 |
Blasticidin | DOT1L O-GlcNAcylation promotes its protein stability and MLL-fusion leukemia ... | 2021 | Cell Rep | Song T. et al. | DOI: 10.1016/j.celrep.2021.109739 |
Puromycin | DOT1L O-GlcNAcylation promotes its protein stability and MLL-fusion leukemia ... | 2021 | Cell Rep | Song T. et al. | DOI: 10.1016/j.celrep.2021.109739 |
Normocin® - Antimicrobial Reagent | Atypical TNF-TNFR superfamily binding interface in the GITR-GITRL complex for... | 2021 | Cell Rep. | Zhao M. et al. | DOI: 10.1016/j.celrep.2021.109734 |
Zeocin® | Atypical TNF-TNFR superfamily binding interface in the GITR-GITRL complex for... | 2021 | Cell Rep. | Zhao M. et al. | DOI: 10.1016/j.celrep.2021.109734 |
QUANTI-Luc™: Luciferase Detection Reagent | Atypical TNF-TNFR superfamily binding interface in the GITR-GITRL complex for... | 2021 | Cell Rep. | Zhao M. et al. | DOI: 10.1016/j.celrep.2021.109734 |
Jurkat Reporter Cells (NFAT) | Atypical TNF-TNFR superfamily binding interface in the GITR-GITRL complex for... | 2021 | Cell Rep. | Zhao M. et al. | DOI: 10.1016/j.celrep.2021.109734 |
NF-κB and NLRP3 inflammasome inhibitor - BAY 11-7082 | Tumor Necrosis Factor-alpha utilizes MAPK/NFκB pathways to induce cholesterol... | 2021 | PLoS One | Pokharel S.M. et al. | DOI: 10.1371/journal.pone.0257576 |
SB203580 | Tumor Necrosis Factor-alpha utilizes MAPK/NFκB pathways to induce cholesterol... | 2021 | PLoS One | Pokharel S.M. et al. | DOI: 10.1371/journal.pone.0257576 |
Nigericin | SFTSV Infection Induced Interleukin-1β Secretion Through NLRP3 Inflammasome A... | 2021 | Front Immunol. | Liu J.W. et al. | DOI: 10.3389/fimmu.2021.595140 |
Caspase-1 and Caspase-4 inhibitor | SFTSV Infection Induced Interleukin-1β Secretion Through NLRP3 Inflammasome A... | 2021 | Front Immunol. | Liu J.W. et al. | DOI: 10.3389/fimmu.2021.595140 |
NF-κB and NLRP3 inflammasome inhibitor - BAY 11-7082 | Yes-Associated Protein Is Required for ZO-1-Mediated Tight-Junction Integrity... | 2021 | Biomedicines | Kim S.Y et al. | DOI: 10.3390/biomedicines9091264 |
Puromycin | Yes-Associated Protein Is Required for ZO-1-Mediated Tight-Junction Integrity... | 2021 | Biomedicines | Kim S.Y et al. | DOI: 10.3390/biomedicines9091264 |
LPS-EK (LPS from E. coli K12) | Chitin Glucan Shifts Luminal and Mucosal Microbial Communities, Improve Epith... | 2021 | Nutrients | Calatayud M. et al. | DOI: 10.3390/nu13093249 |
QUANTI-Blue™ | Chitin Glucan Shifts Luminal and Mucosal Microbial Communities, Improve Epith... | 2021 | Nutrients | Calatayud M. et al. | DOI: 10.3390/nu13093249 |
THP1-Blue™ NF-κB Cells | Chitin Glucan Shifts Luminal and Mucosal Microbial Communities, Improve Epith... | 2021 | Nutrients | Calatayud M. et al. | DOI: 10.3390/nu13093249 |
LPS-EB (LPS from E. coli O111:B4) | Endothelial Poldip2 regulates sepsis-induced lung injury via Rho pathway acti... | 2021 | Cardiovasc Res. | Dolmatova E.V. et al. | DOI: 10.1093/cvr/cvab295 |
QUANTI-Luc™: Luciferase Detection Reagent | Intratumoral combination therapy with poly(I:C) and resiquimod synergisticall... | 2021 | J Immunother Cancer | Anfra C. et al. | DOI: 10.1136/jitc-2021-002408 |